French healthcare company Sanofi SA has agreed to buy U.S. company Principia Biopharma Inc for around $3.7 billion, the companies said on Monday, strengthening Sanofi’s presence in research and development...
India Life Sciences Fund invests ₹100 cr in Inventia Healthcare
Adding to the spree of private equity investments in the Indian pharmaceutical sector, India Life Sciences Fund III has invested ₹100 crore in Inventia Healthcare Ltd. Inventia, with its R&D centre and manufacturing...
CureVac in talks with pharma companies about partnership: Sueddeutsche
German biotechnology firm CureVac CVAC.O is in talks with large drugmakers about a partnership to help market and distribute its prospective vaccine against the COVID-19 virus, its chief executive told Sueddeutsche...
Mankind Pharma partners with South Korea’s Daewoong for Covid drug
Delhi-based Mankind Pharma and South Korea’s Daewoong Pharmaceutical company have joined hands to conduct clinical trials of anti-parasitic drug niclosamide for Covid-19. Daewoong’s Indian subsidiary will...
Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccine
Vaccine manufacturers globally have the capacity to produce 2-4 billion doses of Covid-19 vaccines till the end of 2021, according to a survey by the Coalition for Epidemic Preparedness Innovations (CEPI). The study was...
U.S. to pay $2.1 billion to Sanofi, GSK, in COVID-19 vaccine deal
The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drugmakers’ testing and manufacturing, the companies said on Friday...
Tata Capital to pick minority stake in Biocon Biologics for $30 million
Private equity (PE) player Tata Capital is set to pick up a minority 0.85 per cent stake for $30 million in the biologics arm of biopharmaceutical major Biocon, the Bengaluru-based company said on Friday. This new round...
Advent to acquire RA Chem Pharma
Adding to a spate of private equity (PE) investments in the Indian pharma sector this year, PE firm Advent International on Thursday said it has signed a definitive agreement to acquire a controlling stake in RA Chem...
Sanofi lifts earnings view as Regeneron stake sale boosts second quarter
Sanofi raised its 2020 earnings forecast on Wednesday after its second-quarter results were boosted by cost cuts and the sale of most of its 20.6% stake in U.S. company Regeneron, although revenue was hit by...
Taro Pharma to acquire Canada’s Aquinox Pharmaceutical for $8.2 million
Drug major Sun Pharma on Wednesday said a subsidiary of its American arm Taro Pharmaceutical will acquire Canada’s Aquinox Pharmaceutical for $8.2 million (approx Rs61.35 crore) in cash. Aquinox Pharmaceuticals is...
Emergent signs $174 million deal to make AstraZeneca’s potential COVID-19 vaccine
Emergent BioSolutions Inc said on Monday it signed a $174 million agreement with AstraZeneca to develop and manufacture the British drugmaker’s COVID-19 vaccine candidate. AstraZeneca in June picked Emergent to help...
Alembic set to raise $150-200 million via stake sale
Alembic Pharmaceuticals is set to raise $150-200 million by selling shares to institutional investors, three people close to the fundraising plans said, as the Gujarat-based pharmaceutical firm looks to cut debt and...
